Skip to main content

Aclaris Therapeutics, Inc. (NASDAQ: ACRS) Investor Securities Class Action Lawsuit 07/30/2019

  • You must submit the settlement "Proof" form attached below, in order to participate in this settlement. There is a strict deadline of December 7, 2021 by which all claims must be submitted. The instructions for submitting are included in the "Proof" and the "Notice" files attached below for your download. DO NOT SEND THE FORMS TO THE SHAREHOLDERS FOUNDATION, INC.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

December 9, 2021 -  The court granted final approval of the settlement. August 18, 2021 - The court preliminarily approved the settlement. July 30, 2021 - A stipulation of settlement was filed by the parties. January 24, 2020 - An amended complaint was filed. July 30, 2019 - An investor in shares of Aclaris Therapeutics, Inc. (NASDAQ: ACRS) filed a lawsuit in the U.S. District Court f...

You must register (for free) or login to view the entire case.